BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19737771)

  • 1. Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat.
    Lamm CG; Stern AW; Smith AJ; Cooper EJ; Ullom SW; Campbell GA
    J Vet Diagn Invest; 2009 Sep; 21(5):710-5. PubMed ID: 19737771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous mast cell tumor with epitheliotropism in 3 dogs.
    Oliveira FN; Elliott JW; Lewis BC; Mathews GG; Brown RM; Treadway CM; Langohr IM
    Vet Pathol; 2013 Mar; 50(2):234-7. PubMed ID: 22700850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mastocytosis in the skin in dogs: A multicentric case series.
    Wyatt EK; Affolter V; Borio S; Guillen A; Verganti S; Murphy S; Ballarini D; Banovic F; Schmidt V; Tanis JB
    Vet Comp Oncol; 2024 Mar; 22(1):136-148. PubMed ID: 38243867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a c-kit exon 8 internal tandem duplication in a feline mast cell tumor case and its favorable response to the tyrosine kinase inhibitor imatinib mesylate.
    Isotani M; Tamura K; Yagihara H; Hikosaka M; Ono K; Washizu T; Bonkobara M
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):168-72. PubMed ID: 16908071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KIT receptor in feline cutaneous mast cell tumors.
    Rodriguez-Cariño C; Fondevila D; Segalés J; Rabanal RM
    Vet Pathol; 2009 Sep; 46(5):878-83. PubMed ID: 19429979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous mast cell tumor and mastocytosis in a black-masked lovebird (Agapornis personata).
    Dallwig RK; Whittington JK; Terio K; Barger A
    J Avian Med Surg; 2012 Mar; 26(1):29-35. PubMed ID: 22645837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.
    Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M
    Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical characterization of feline mast cell tumors.
    Mallett CL; Northrup NC; Saba CF; Rodriguez CO; Rassnick KM; Gieger TL; Childress MO; Howerth EW
    Vet Pathol; 2013 Jan; 50(1):106-9. PubMed ID: 22492208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
    J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Occult" mastocytosis with activating c-kit point mutation evolving into systemic mastocytosis associated with plasma cell myeloma and secondary amyloidosis.
    Sotlar K; Saeger W; Stellmacher F; Stahmer J; Jäckle S; Valent P; Horny HP
    J Clin Pathol; 2006 Aug; 59(8):875-8. PubMed ID: 16873565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous and splenic mastocytosis in a juvenile Malayan tiger.
    Smedley RC; Stedman NL; Kiupel M
    J Vet Diagn Invest; 2022 Mar; 34(2):288-291. PubMed ID: 35075959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-KIT-Positive Fatal Diffuse Cutaneous Mastocytosis With Systemic Manifestations in a Neonate.
    Chaudhary N; Shapiro N; Bhutada A; Rastogi S
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):e338-e340. PubMed ID: 30067557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
    Sabattini S; Bettini G
    Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
    Wiednig M; Beham-Schmid C; Kranzelbinder B; Aberer E
    Dermatology; 2013; 227(1):67-71. PubMed ID: 24008407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
    Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
    J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonality and molecular pathogenesis of mastocytosis.
    Akin C
    Acta Haematol; 2005; 114(1):61-9. PubMed ID: 15995326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
    Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM
    Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.